EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic profile at the time of surgery correlates with disease stage and surgical outcome in periprosthetic joint infection

Kathleen O'Connor iD, Christina Koscianski, Nicholas Larson, Kiran K Mangalaparthi, Cody Hoffmann, Nicholas A Bedard, Khaled Elmenawi, Merrick T Ducharme, Jessica D Hohenstein, Daniel O'Brien, Akhilesh Pandey, Robin Patel iD

mBio · 2025

DOI: 10.1128/mbio.01700-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Kathleen O'Connor und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Proteomics, Proteome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Mayo Clinic Proteomics Core, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periprosthetic joint infection (PJI) is the most common and difficult to treat form of arthroplasty failure. While treatment with debridement, antibiotics, and implant retention (DAIR) is preferable to one- or two-stage implant exchange based on morbidity and cost, outcomes are not successful in all cases selected for this management strategy. DAIR is currently recommended when infection is perceived to be in an “acute” phase, based on symptom duration; despite this selection strategy, DAIR failure rates are high. A more objective means of predicting DAIR success could improve patient outcomes by limiting DAIR failures. To explore this possibility, advanced proteomic analysis of sonicate fluid samples from 95 subjects with PJI was performed using proximity extension assay (PEA), with 77 samples additionally undergoing complementary proteomics analysis with liquid chromatography with tandem mass spectrometry (LC-MS/MS). Sparse partial least squares differentiation analysis (sPLS-DA) separated samples from patients who underwent DAIR with known outcomes ( n = 19) into successful or unsuccessful groups, predicting DAIR surgical outcome (area under the curve [AUC]: 1; mean “leave one out” AUC: 0.6). Proteins predictive of DAIR surgical outcome were significantly enriched for the “protein repair” Gene Ontology (GO) pathway ( P -adj = 0.02). Additionally, proteomic signatures associated with symptom duration in PJI categorized samples into short and long symptom duration PJI. In summary, an investigation of 7,261 unique human proteins separated PJI-associated samples based on symptom duration and identified a proteomic profile predictive of DAIR success. IMPORTANCE Chronic infections are generally understood to last months to years, with acute infections lasting days to weeks. The transition from acute to chronic infection is, however, poorly understood. Periprosthetic joint infection (PJI) has been considered more challenging to treat when “chronic” than when “acute.” A surgery preferred for its recovery time and cost—debridement, antibiotics, and implant retention (DAIR)—is recommended for PJI management when symptom duration is short; yet, even in this select patient group, DAIR is associated with a high treatment failure rate. A means to better identify those predicted to have a successful outcome if they undergo DAIR is needed. Here, over 7,000 proteins from human clinical PJI samples were measured and shown to be able to separate samples based on symptom duration. Importantly, a proteomic profile predictive of DAIR success was identified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsProteomicsProteomeHumansMaleFemaleAgedMiddle AgedTreatment OutcomeChromatography, LiquidTandem Mass SpectrometryAged, 80 and overDebridement

Stichwörter der Autor:innen

acute infectionchronic infectionimmunologyprosthetic joint infectionproteomics

Substanzen

Proteome

Autor:innen und Institutionen

  • Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Manipal Academy of Higher Education, Manipal, Karnataka, India.

ORCID-Profile: Kathleen O'Connor, Robin Patel

Förderung

  • NIAMS NIH HHS
  • Mayo Clinic Proteomics Core
  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Musculoskeletal Research Training Program

Zitieren

APA

O'Connor, K., Koscianski, C., Larson, N., Mangalaparthi, K. K., Hoffmann, C., Bedard, N. A., Elmenawi, K., Ducharme, M. T., Hohenstein, J. D., O'Brien, D., Pandey, A., & Patel, R. (2025). Proteomic profile at the time of surgery correlates with disease stage and surgical outcome in periprosthetic joint infection. mBio. https://doi.org/10.1128/mbio.01700-25

Vancouver

O'Connor K, Koscianski C, Larson N, Mangalaparthi KK, Hoffmann C, Bedard NA, et al. Proteomic profile at the time of surgery correlates with disease stage and surgical outcome in periprosthetic joint infection. mBio. 2025. doi:10.1128/mbio.01700-25

BibTeX
@article{OConnor2025,
  author = {O'Connor, Kathleen and Koscianski, Christina and Larson, Nicholas and Mangalaparthi, Kiran K and Hoffmann, Cody and Bedard, Nicholas A and Elmenawi, Khaled and Ducharme, Merrick T and Hohenstein, Jessica D and O'Brien, Daniel and Pandey, Akhilesh and Patel, Robin},
  title = {Proteomic profile at the time of surgery correlates with disease stage and surgical outcome in periprosthetic joint infection},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.01700-25}
}
Kostenlos starten →